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Abstract
Background: Proteins may evolve through the recruitment and modification of discrete domains, and in many
cases, protein action can be dissected at the domain level. PDZ domains are found in many important structural
and signaling complexes, and are generally thought to interact with their protein partners through a C-terminal
consensus sequence. We undertook a comprehensive search for protein partners of all individual PDZ domains in
C. elegans to characterize their function and mode of interaction.
Results: Coupling high-throughput yeast two-hybrid screens with extensive validation by co-affinity purification,
we defined a domain-orientated interactome map. This integrates PDZ domain proteins in numerous cell-signaling
pathways and shows that PDZ domain proteins are implicated in an unexpectedly wide range of cellular processes.
Importantly, we uncovered a high frequency of non-canonical interactions, not involving the C-terminus of the
protein partner, which were directly confirmed in most cases. We completed our study with the generation of a
yeast array representing the entire set of PDZ domains from C. elegans and provide a proof-of-principle for its
application to the discovery of PDZ domain targets for any protein or peptide of interest.
Conclusions: We provide an extensive domain-centered dataset, together with a clone resource, that will help
future functional study of PDZ domains. Through this unbiased approach, we revealed frequent non-canonical
interactions between PDZ domains and their protein partners that will require a re-evaluation of this domain’s
molecular function.
[The protein interactions from this publication have been submitted to the IMEx (http://www.imexconsortium.org)
consortium through IntAct (PMID: 19850723) and assigned the identifier IM-14654]
Background
Because of its biological importance, the PDZ (PSD-95,
Discs-large, ZO-1) domain has been intensively studied
at the structural and functional level. Proteins contain-
ing PDZ domains frequently serve as molecular scaf-
folds, which assemble signaling complexes needed for
efficient and specific signal transduction at defined sub-
cellular sites, such as at polarized epithelial cell junc-
tions, or synapses in neurons [1-3]. Early work indicated
a preferential interaction between PDZ domains and the
C-terminal amino acids of target proteins [4]. In some
cases, removal of the 3 C-terminal residues of the part-
ner protein abrogates interaction with the PDZ domain
[5]. Much subsequent effort has been put into bioinfor-
matic studies and small- and large-scale screens to
refine the exact sequence of this presumed C-terminal
motif [5-10], leading to several consensus sequences,
with different degrees of refinement (e.g. Additional file
1; [1,10-12]). Individual proteins can contain multiple
PDZ domains. For example, the human multiple PDZ
domain protein (MPDZ) has 13. When their interactions
with other proteins have been dissected, the different
PDZ domains of a single protein often have been found
to have distinct binding partners (see for example the
Uniprot entry for MPDZ [13]). PDZ domain proteins
have also been used in the context of large-scale
searches for protein partners. For example, global
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interactions of 25 of the nematode’s 62 PDZ domain
proteins. Although these 25 proteins were found to be
involved in 218 interactions, whether the different PDZ
domains played a direct role was not addressed [14,15].
No comprehensive, proteome-wide screen using all PDZ
domains, however, has been reported for any organism.
Here, we describe the characterization and cloning of
e v e r ys i n g l eo n eo ft h e9 3P D Zd o m a i n sf r o mC. ele-
gans. We generated a versatile resource, with each
domain in the Gateway system, allowing facile transfer
to different expression systems. As an example, we
made a yeast array of the 93 PDZ domains and provide
a proof-of-principle for its application to the discovery
of PDZ domain targets for any protein or peptide of
interest. In addition, from a separate yeast two-hybrid
(Y2H) screen, we identified more than 650 potential
partners for these domains. A large number of these
interactions were independently validated using a co-
immunoprecipitation approach. An analysis of these
interactors implicates PDZ domains in a broad range of
cellular functions. Unexpectedly, many of the interac-
tions did not involve a C-terminal consensus sequence,
suggesting that PDZ domains frequently bind their part-
ners in a hitherto uncharacterized mode.
Results
An interactome map for PDZ domains
We chose to define the interaction partners of all the
PDZ-domain proteins in C. elegans. Through an exhaus-
tive cross-database search, we identified a total of 93
PDZ domains in 62 distinct proteins, not counting iso-
forms sharing domains (see Additional file 2: Supple-
mental Table S1). Among these PDZ-domain containing
proteins, only 44% were associated with any gene ontol-
ogy annotation based on experimental data ([16]; Addi-
tional file 2: Supplemental Table S2). The DNA for all
93 domains was amplified and cloned. The insert for
each clone was sequenced-verified, and this comprehen-
sive clonal collection, in the Gateway entry vector
allowing rapid transfer into multiple other vectors
[17,18], is available as a community resource upon
request. The inserts were all transferred into a DB-
vector and used in high-stringency Y2H screens against
the non-normalized cDNA library AD-wrmcDNA [18].
We pulled out 447 interactions involving 317 interacting
proteins and 75 individual PDZ domains. 6 PDZ
domains were auto-activators and therefore not included
in the screen, thus 81% of the PDZ domains gave at
least 1 interaction, with a mean of 6 interacting proteins
(see Additional file 3: Supplemental Tables S3, S4 and
S5). As expected, there was limited overlap with the
results of the previous global C. elegans Y2H screens
due in part to the incomplete and disparate degrees of
coverage (6 shared interactions with Worm Interactome
8 [15]), and the domain-nature of the current screen.
We did observe a clear bias towards proteins containing
C-terminal class I consensus motifs (as defined in Addi-
tional file 1). One striking observation, however, was the
high frequency (51%) of interacting proteins that did not
possess a classical C-terminal consensus sequence
(Table 1; Additional file 3: Supplemental Table S6). This
trend was maintained even when interacting proteins
that had multiple PDZ-domain partners were counted
only once in the analysis (Table 1). This opened the
possibility to perform a second screen using the AD-
ORFeome library [19], which has the advantage of being
highly normalized. In this library, the stop codon of
each insert is replaced by the B2 recombination
sequence, giving rise to proteins with a constant non-
native C-terminal extension. These additional 8 amino
acids (PAFLYKVV) do not correspond to the consensus
binding sequence for native PDZ-domains. Using this
library, we identified a total of 227 interactions involving
178 interacting proteins and 59 PDZ domains (see Addi-
tional file 3: Supplemental Table S3). These included 14
in common with the cDNA screen. This degree of over-
lap (6%) is slightly lower than that reported [14,19] for
previous screens against the two libraries (14% and 16%,
respectively), possibly reflecting the fact that our PDZ
Table 1 Proportions of C-terminal consensus classes in interacting proteins
consensus class 1 consensus class 2 consensus class 3 total consensus total non consensus
AD-wrmcDNA library 20% 24% 5% 49% 51% n = 447
AD-ORFeome library 10% 18% 5% 33% 66% n = 227
C. elegans proteome 8% 18% 5% 31% 69% n = 20186
consensus class 1 consensus class 2 consensus class 3 total consensus total non consensus
AD-wrmcDNA library 18% 21% 5% 44% 56% n = 317 nr
AD-ORFeome library 9% 15% 4% 28% 72% n = 178 nr
C. elegans proteome 8% 18% 5% 31% 69% n = 20186
Proportions of C-terminal consensus classes for interacting proteins identified in AD-wrmcDNA and AD-ORFeome screens compared with proportions ofC -
terminal consensus classes in the complete C. elegans proteome (WS190 [16]) are given. Consensus class 1: [ST]X[FWCYMVILA], Consensus class 2 [YFWCMVILA]X
[YFWCMVILA], Consensus class 3 [DE]X[YFWCMVILA] (X: any amino acid). Upper panel: proportions calculated using all PDZ-interacting protein pairs, lower panel:
proportions calculated using each interacting protein only once when interacting with multiple PDZ domains (nr stands for non-redundant).
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consensus motifs, which are not accessible in the
AD-ORFeome library. Within these 59 PDZ domains
(63% of the total; mean 3.8 interacting proteins per
domain; see Additional file 3: Supplemental Tables S4
and S5), the prevalence of C-terminal consensus
sequences in the interacting proteins reflected that seen
in the proteome as a whole (Table 1; Additional file 3:
Supplemental Table S6). Taken together, these results
suggest that some PDZ domains might interact with
their target ligands outside the C-terminus much more
often than expected.
Characteristics of PDZ domain interacting proteins
Pooling the results from the two screens, we obtained
674 interactions involving 469 proteins and 78 PDZ
domains (from 55 proteins out of the original 62)(Figure
1A). In many cases, single proteins were found to inter-
act with multiple PDZ domains (Figure 1B), consistent
with the known promiscuity of ligand-PDZ domain
interactions [20]. Gene Ontologies (GO) [21] analysis
a r el i m i t e db yt h ef a c tt h a to n l y1 8 2 / 4 6 9p r o t e i n sh a v e
attributes inferred from experimental evidence. We
therefore opted to extend this analysis with a manual
curation of our protein set based principally on Worm-
base [16] annotations (Figure 2, Additional file 4: Sup-
plemental Tables S7, S8 and S9). PDZ domains have
long been known to be involved in the scaffolding of
proteins complexes at the plasma membrane thus con-
tributing to the signaling specificity of many receptors,
notably at the synapse [22], or to the establishment and
maintenance of epithelial polarity [2,23]. Indeed, just
under half of the functionally annotated proteins are
involved in signaling (protein kinases, GTPases and
phosphatases), structural maintenance or transport. The
annotation of the other PDZ interacting proteins reveals
a broad range of functions ranging from metabolism,
ubiquitination, RNA binding and processing to tran-
scriptional regulation (Figure 2). Interestingly some stu-
dies indicate nuclear roles for PDZ domain proteins. For
example, the junctional protein ZO-2 directly interacts
in the nucleus with the DNA-binding protein scaffold
attachment factor-B (SAF-B) [24].
Frequent use of non-consensus binding confirmed by
co-IP
It is well established that some Y2H interactions do not
reflect a physiologically relevant binding events between
proteins. Ideally, these interactions need to be validated
in vivo. Such tests are fastidious and not compatible
with large-scale studies. We therefore sought to assay a
subset of our Y2H interactions, using a very distinct
experimental system, namely co-affinity immunoprecipi-
tations (co-IP) from human 293T cells. First, we choose
13 different interactions, found in the cDNA screen,
involving 11 PDZ domains and 9 interacting proteins.
All these interactions were detected by co-IP using con-
structs encompassing the PDZ interacting full-length
proteins, with their native C-terminus (Figure 3, Addi-
tional file 5: Supplemental Table S10). We then
extended the co-IP test and used B2-tagged constructs,
i.e. giving proteins with a non-native and non-consensus
C-terminus (see above), to test 38 putative interactions.
Of these, we could test 31 interactions (15 from the
cDNA screen, 9 from AD-ORFeome screen, and 7 from
both. 27 interactions (87%) detected by Y2H were repro-
duced in these tests, including 12/15 cases where the
Y2H interaction had originally been found only in the
cDNA screen using constructs with a native C-terminus
(see Additional file 6, Additional file 5: Supplemental
Table S11). We thus confirmed many interactions
between PDZ domains and proteins with a non-native
and/or non-consensus C-terminus. To investigate
further the possibility that these PDZ domains were
interacting with an internal sequence in the partner pro-
tein, we returned to a set of high-confidence interac-
tions found in the cDNA screen. For 59 proteins
(corresponding to 74 interactions) that did not possess a
canonical consensus C-terminal, we cloned derivatives
corresponding to the entire protein less the 3 last
residues, or when possible the experimentally defined
minimal interacting region (MIR), also without the 3 C-
terminal residues. This was to ensure that observed
interaction did not depend on the native C-terminal
residues. Using co-IP, we found that 52/65 interactions
(80%) successfully tested could be reproduced in the co-
IP system even in the majority of cases when removal of
the terminal residues did not create a new consensus
binding site (Figure 4, Additional file 7, Additional
file 5: Supplemental Tables S12 and S13). We are there-
fore confident that the dataset that we provide will be a
useful source of information to direct studies of PDZ-
domain signaling pathways.
A Y2H array as a tool to probe PDZ domain binding
Many true interactions protein-protein interactions are
missed in Y2H library screens. This high rate of false
negatives can be partially alleviated by performing direc-
ted Y2H assays [25-27]. We therefore decided to con-
struct a Y2H interaction array that would allow
candidate proteins to be screened for their binding capa-
city to the comprehensive set of PDZ domains. For this,
we took a collection of yeast strain each expressing a
single PDZ-domain from an Y2H AD-vector, and
spotted them in a standard 8 × 12 format on a solid
agar support. The individual domains on the array can
be probed by introducing into each strain a vector
allowing the expression of a protein of interest, using a
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Figure 1 Yeast two-hybrid interactome maps of PDZ domain interactions. Grey nodes represent individual PDZ domains, blue nodes
represent interacting proteins having a C-terminal consensus sequence (as defined in Additional file 1) and red nodes represent interacting
proteins that do not have a C-terminal consensus sequence. Red edges represent interactions identified in the AD-ORFeome yeast two-hybrid
screen and black edges represent interactions identified in the AD-wrmcDNA yeast two-hybrid screen. (A) Global representation of the 674
interactions involving 469 proteins and 78 PDZ domains. (B) Promiscuity: representation of interactions involving selected target proteins with
multiple PDZ domains. For multiple PDZ domains in the same protein, a “.n” extension numbered from the ATG was added to the ID of the PDZ
containing protein. Some interactions have been omitted for the sake of clarity. Graphs were designed using VisANT [53].
Lenfant et al. BMC Genomics 2010, 11:671
http://www.biomedcentral.com/1471-2164/11/671
Page 4 of 11standard Y2H approach. To test the utility of the
resource, we first conducted parallel matings with a
yeast strain expressing NRX-1, the C. elegans ortholog
of vertebrate neurexin, which plays a critical role in
synaptic development (Figure 5). Consistent with the
results of our Y2H screen that had identified NRX-1 as
an interactor of SYD-1, we found SYD-1 as a partner
for NRX-1 using the array. SYD-1 is also a regulator of
synaptogenesis. We also identified an additional 4 bind-
ing partners, including the single PDZ domain contain-
ing STN-2, a gamma syntrophin, and MPZ-1 that can
be found at synapses. MPZ-1 has 10 PDZ domains and
we detected an interaction only with the 9th domain.
We also screened the array with LET-23 and identified
4 proteins, including its known partner LIN-7 [28] (data
not shown). On the other hand, when we screened the
array with PAC-1, we found PAR-6, which has been
demonstrated to be its physiological functional partner
[29] (data not shown). Similarly, the sole interactor
identified for PRY-1, a negative regulator of Wnt signal-
ing, was MIG-5, one of three C. elegans Dishevelled
homologs that functions in both canonical and non-
canonical Wnt signaling pathways (Figure 5). Neither of
the other 2 Dishevelled homologs were detected as
interacting with PRY-1, consistent with previous studies
[30].
Discussion
We constructed a comprehensive, proteome-wide inter-
action map for all the PDZ domains from C. elegans.
Importantly, for a substantial proportion of the interac-
tions, we were able to obtain independent biochemical
confirmation. The interactions we characterized covered
a broad range of putative biological functions, reflecting
the ubiquitous involvement of PDZ-domain proteins in
cellular physiology. Although a number of PDZ-domain
proteins have been functionally characterized in great
details, in very few cases has a role for an individual
PDZ-domain been identified. We did find a small group
of interactions involving PDZ-domains protein for
which there was prior experimental evidence, such as
those involving LET-23 and LIN-7, and PAR-3 and
PKC-3 [28,31]. Further, we were able to provide a mole-
cular basis for certain previously characterized genetic
interactions (e.g. between the polarity gene par-6 and
the RhoGAP pac-1 [29]). There were many additional
interactions that could merit directed study, such as that
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Figure 2 Classification of interacting proteins according to
Biological Processes. Manual curation of the annotations for each
interacting protein when available were retrieved from Wormbase
WS190 [16] and used to define the 11 groups of processes shown.
PDZ domain proteins appear to be involved in a disparate range of
functions.
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Figure 3 Co-IP verification of yeast two hybrid interacting pairs
identified in AD-wrmcDNA screen. (A) Schematic representation
of PDZ domains carrying N-terminal 3XHA epitope tag and of their
full-length interaction partner terminated with a stop codon (ORF*)
carrying N-terminal MYC epitope. Each corresponding pair of
constructs to be tested was co-expressed in 293T cells and cellular
lysates were subjected to precipitation with anti-HA Sepharose. (B)
Presence of interacting protein upon precipitation was revealed by
western blotting using anti-MYC serum. For each IP performed
three panels are presented. Upper panel: IP reaction probed upon
resolution on SDS-PAGE and blotting with anti-HA antibody
detecting HA-PDZ domain; Middle panel: the same IP reaction
probed with anti-MYC serum detecting ORF (MYC:ORF*); lower
panel: detection of expression of each ORF by probing total crude
cellular extracts (input) with anti-MYC serum. Table summarizes the
interaction pairs tested.
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22 C52A11.4.3 C39D10.7 37 59 C52A11.4.8 B0001.6 29
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28 F54E7.3.3 C18A11.7 23 65 T14G10.2 R06F6.12 18
29 F54E7.3.3 C27A12.7 50 66 T26E3.3 R06F6.12 18
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36 T05C12.6 R04E5.10 46 73 T26E3.3 F53B3.1 59
37 T05C12.6 Y37E11AL.3 34 74 T26E3.3 Y77E11A.7 63
Figure 4 Verification of internal binding of PDZ-domain and non-consensus C-terminally truncated protein partner by co-
immunoprecipitation. (A) Schematic representation of both tagged proteins: PDZ domains carrying an N-terminal 3XHA epitope tag and C-
terminally truncated (dCter) Y2H interacting protein fragment (MIR: experimentally defined minimal interaction region) carrying N-terminal MYC
epitope. (B) All pairs were co-expressed in 293T cells and co-IPed using anti-HA sepharose beads. Binding of given protein upon precipitation
was revealed by western blotting using anti-MYC serum. For each IP performed three panels are presented. Upper panel: IP reaction probed
after resolution on SDS-PAGE and blotting with anti-HA antibody. Middle panel: the same IP reaction probed with anti-MYC serum detecting the
truncated protein fragments (MYC:MIRdCter). Lower panel: detection of expression of each truncated protein fragment by probing total crude
cellular extracts (input) with anti-MYC serum. The table identifies interaction pairs by their lane number and order in which they are presented in
blot panels. The color code summarizes the outcome for each pair (purple: interaction tested positive, grey: no interaction detected and yellow:
inconclusive as one or both partners were not expressed). Each MYC:MIRdCter construct used in above co-IP experiment was also subjected to
co-transfection and co-immunoprecipitation with empty pDEST-CMV-3xHA vector to serve as a negative control for the binding assay (see
Additional file 7).
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Page 6 of 11between PTEN/DAF-18 and Dishevelled/DSH-1, two
proteins that function respectively in the PTEN/AKT
and WNT pathway, and the multipartite interaction
between LIN-7 and CSC-1, and LIN-10 with CSC-1 and
ICP-1. The LIN-2/LIN-7/LIN-10 complex is known for
its role in basolateral targeting of the LET-23 receptor.
CSC-1 and ICP-1 are orthologs of Borealin and Incenp
two components of the vertebrate chromosomal passen-
ger complex (CPC). We confirmed CSC-1’s interactions
and the interactions between the two PDZ domains of
LIN-10 with ICP-1 using a biochemical approach (JP,
unpublished results). This raises the possibility of an
unsuspected functional link between these two protein
complexes, and is a good example of the hypotheses
that can be generated through global analyses.
As a last example, both via our global screen and using
the PDZ-domain array, we detected an interaction
between MIG-5 and PRY-1. Previous studies had mapped
the interaction between PRY-1 and MIG-5 to the
N-terminal half of MIG-5 [30], which does contain the
protein’s single PDZ domain. The C-terminus of PRY-1
(IAAELR) does not contain a consensus PDZ-binding
motif. This therefore represents a clear example of a
functionally validated protein-protein interaction that we
have shown to involve a non-canonical PDZ domain
interaction. Indeed, more than half of the interactions
did not involve the previously defined PDZ-domain bind-
ing C-terminal motifs. By aligning and analyzing our set
of PDZ-interacting proteins, we were unable to identify a
clear internal motif that could be uniquely responsible
for PDZ domain binding. Nevertheless, this global study
clearly indicates that non-consensus binding is a much
more frequent phenomenon than previously suspected.
Extensive future functional studies will be needed to vali-
date all the individual internal PDZ domains interactions
described here, but it is important to note that in certain
isolated cases, this unconventional mode of binding has
been demonstrated [32-42].
It is clear that global Y2H screens only reveal a frac-
tion of potential protein-protein interactions [43].
Among other factors, this is due to cDNA representa-
tion in non-normalized libraries. This was one motiva-
tion for generating an array that allows direct Y2H assay
of any protein or peptide of interest against a complete
set of PDZ domains. Coupled with the collection of
PDZ domain sequences in the Gateway entry vector,
allowing facile transfer to vectors for RNAi, or protein
expression, the array, which is available as a community
resource, will allow comprehensive functional analyses
of all PDZ domains in C. elegans.
Conclusions
By conducting a comprehensive, domain-centered inter-
a c t o m es t u d y ,w eh a v ec l e a r l yi l l u s t r a t e da tt h eg e n o m e
scale the degree of promiscuity and discrimination that
governs interactions between individual PDZ domains
and their protein partners. This approach also revealed
that PDZ domains frequently interact in a non-canonical
fashion. This broadens our understanding of PDZ
domains and should guide future functional studies.
Methods
PDZ domain identifications in C. elegans proteome
Domain boundaries where obtained by cross searching
Wormbase WS150 [44] and SMART version 4.0 (geno-
mic mode) (http://smart.embl-heidelberg.de) [45]. Each
domain was extended on each side with a 10 amino acid
tail from the original protein to ensure the integrity of
the structure of the domain. In some cases size of these
tails had to be slightly modified according to the posi-
tion of the PDZ in protein (extreme end or start) or to
ensure a correct amplification.
PDZ domain cloning
Primers, containing Gateway B1 and B2 recombination
tails, were designed using the OSP program as described
[46,47] including a stop codon before the B2 tail (see
Additional file 2: Supplemental Table S1). DNA frag-
ments encoding each PDZ domain where amplified by
polymerase chain reaction (Platinum HIFI polymerase,
Invitrogen) and cloned into pDONR201 Entry vector
using the Gateway recombinational cloning system as
described [17,18]. PDZ Entry clones were sequence veri-
fied using P201DONRF primer 5’-TCGCGTTAACGC-
TAGCATGGATCTC and then used in a Gateway LR
Non-selective
Selective
NRX-1 PRY-1
Figure 5 Y2H array for detecting interactions with PDZ
domains. An array of yeast strains each expressing one of the 93 C.
elegans PDZ domains, together with a marker permitting growth on
medium lacking leucine, and containing a second vector allowing
growth on medium lacking tryptophan as well as expressing NRX-1
(left-hand panels) and PRY-1 (right-hand panels), spotted onto solid
agar medium. The upper row shows that all strains grow on
medium lacking leucine and tryptophan indicating that all strains
contain both prey and bait vectors. In the lower row, on fully
selective medium, lacking leucine, tryptophan and histidine, growth
only occurs when there is an interaction between a PDZ domain
and the protein of interest.
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the PDZ domain into the yeast expression vector
pPC97-Dest as described [18].
Transformation of pDB-ORFs into yeast cells and removal
of auto-activators
DB-ORF plasmids were transformed into yeast strain
MaV203 using standard transformation protocols [48].
Auto-activators were identified by testing the activation
of GAL1::HIS3 on minimal medium lacking leucine and
histidine but containing 20 mM 3-amino-1,2,4-triazole
(3-AT) in the absence of any AD-containing vector.
Identification of interacting protein pairs
Bait strains containing a single pDB-PDZ were individu-
ally transformed with the C. elegans AD-wrmcDNA and
AD-ORFeome1.0 libraries [19] as described [48].
A minimum of 1 × 10
6 colonies were screened for each
bait strain tested with the AD-wrmcDNA library and a
minimum of 1.5 × 10
5 colonies were screened for each
bait strain tested with the AD-ORFeome library. After 4
to 5 days at 30°C, single 3-AT resistant colonies were
picked on synthetic complete medium lacking leucine,
tryptophan, and histidine and containing 20 mM 3-AT
(SC, Leu-, Trp-, His-, 20 mM 3-AT) and then rearrayed
on fresh SC, Leu-, Trp-, His-, 20 mM 3-AT plates.
Phenotypic assays
Colonies able to grow on SC, Leu-, Trp-, His-, 20 mM
3-AT plates were tested for expression of three Y2H
reporter genes (GAL1::HIS3, GAL1::lacZ,a n dSPAL10::
URA3, as described [48].
ORF insert sequencing
To prepare DNA for PCR, yeast colonies were re-sus-
pended in 15 μl lysis buffer (50 units zymolase in 0.1 M
Na-Phosphate buffer pH 7.4) using toothpicks, and lysed
by incubating for 10 min. at 37°C and 10 min. at 95°C. For
each PCR, 0.3 μl of lysis mix was used. AD inserts were
amplified using primers 5’-CGCGTTTGGAATCACTA-
CAGGG and 5’-GGAGACTTGACCAAACCTCTGGCG
(AD and TERM respectively). DB inserts were amplified
using primers 5’-GGCTTCAGTGGAGACTGATATGC
CTC (DB) and TERM. PCR products were sequenced
using the AD or DB primers.
Sequence trace analysis
Colonies showing an activation of at least two of the
three Y2H reporter genes were PCR amplified, as
described above. PCR products showing a single band
on ethidium bromide gel were sent for sequencing. The
quality of the sequence obtained was determined as
described [14] by moving a sliding window of 10 base
p a i r sa l o n gt h es e q u e n c et od e f i n et h ep o r t i o nt h a th a s
an average PHRED score of 20 or higher [49,50].
Sequences for which less than 15% of their length met
this criterion were discarded. A nucleotide BLAST [51]
search was performed against Wormpep150 [44] to
determine the identity of the clone. Finally, the reading
frame was obtained by local alignment of the 3’ end of
the Gal4 AD encoding sequence with the 5’ end of the
prey encoding sequence. A translation according to this
reading frame was used to perform a protein BLAST
search against Wormpep150. If the nucleotide and pro-
tein BLAST agreed, the prey encoding sequence was
considered “In Frame”, otherwise it was designated as
“Out of Frame” and discarded.
Retesting
Gap repair was used to retest all Y2H interactions as
described [48]. When an interaction failed to be re-con-
firmed it was discarded from the dataset.
Construction and screening of a comprehensive PDZ
domain Y2H array
All PDZ domains were transferred into AD vector
(pACT2) by Gateway recombinational cloning and trans-
fected into the haploid Y187 yeast strain (MATa, ura3-
52, his3-200, ade2-101, leu2-3, 112, gal4Δ, met-, gal80Δ,
MEL1, URA3::GAL1UAS -GAL1TATA-lacZ).I n d i v i d u a l
ORFs of proteins of interest were cloned into DB vector
(pGBT9) by Gateway recombinational cloning and the
resulting constructs transformed into haploid AH109
yeast strain (MATa, trp1-901, leu2-3, 112, ura3-52, his3-
200, gal4Δ, gal80Δ, LYS2::GAL1UAS-GAL1TATA-HIS3,
GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-MEL1-
TATA-lacZ, MEL1). Interactions between each PDZ and
a given ORF was tested through mating of the two yeast
strains. Phenotypic testing evaluated growth of diploid
cells on selective medium (Leu-, Trp-, His-, 2 mM
3-AT), which is dependent in part upon the expression
of the GAL1::HIS3 selective marker gene.
Co-IP verification of Y2H interacting pairs
To test interactions identified in the AD-wrmcDNA
library Y2H screen using co-IP (Figure 3, Additional file
5: Supplemental Table S10), the full length ORF coding
for the target protein identified was amplified from the
AD-wrmcDNA library, Gateway cloned into the
pDONR201 Entry vector and transferred using the LR
reaction into the expression vector pDEST-CMV-MYC
which contains a MYC tag upstream of the B1 recombi-
nation site. For each fragment the endogenous Stop
codon was preserved before the B2 recombinational tail
(the endogenous C-terminus of the corresponding pro-
tein fragment was preserved).
To test interactions identified in the AD-wrmcDNA or
AD-ORFeome screens, or both (see Additional file 6,
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B2-tailed construct for each PDZ-domain interacting
protein, clones corresponding to the full length protein
in the pDONR201 entry vector were retrieved from the
C. elegans ORFeome collection [19]. Because of the nat-
ure of the constructs used in the ORFeome, LR-transfer
of the ORF into the pDEST-CMV-MYC expression vec-
tor produced a protein ending with the C-terminal
amino-acid sequence PAFLYKVVIIHSSMHLEGPIL (B2
encoding tail + 13 aa on pDEST-CMV-MYC before
Stop codon).
Internal interactions (Figure 4, Additional file 7, Addi-
tional file 5: Supplemental Table S12 and S13) were
tested by co-IP using 74 interactions for which the pair
of PDZ/interacting proteins was found multiple times
through the screening process of the AD-wrmcDNA
library but that had no C-terminal consensus PDZ bind-
ing motif. These interactions corresponded to 59 differ-
ent interacting proteins. To ensure a maximum
reproducibility with the Y2H interactions, sequence data
from the Y2H screen was used to define the smallest
cDNA fragment identified among all clones obtained for
each interaction in the Y2H screen (designated as the
minimal interacting region, or MIR). For each fragment
the codons encoding for the last three amino acid were
removed from the primers and replaced by a Stop codon,
giving rise after PCR amplification, Gateway cloning into
the pDONR201 Entry vector and LR-transfer into the
pDEST-CMV-MYC expression vector, to a cloned frag-
ment encoding a protein lacking the last three amino
acids. This was done to ensure that proteins could not
interact by their native C-terminus, so that a positive
result would provide support for an internal mode of
interaction. When a PDZ-interacting protein was present
in multiple pairs of interactions the smallest cDNA frag-
ment of all pairs was used to test all interactions.
For all Co-IP experiments in this study, DNA encod-
ing each PDZ domains tested was transferred from the
pDONR201 Entry vector to the pDEST-CMV-3xHA
expression vector containing the 3 × HA sequence
upstream of the B1 recombination site.
Plasmids pDEST-CMV-3xHA and pDEST-CMV-MYC
expressing their fusion proteins from the CMV promo-
ters were transfected into 293T cells using Fugen 6
transfection reagent according to the manufacturers
instructions (Roche). Cells were cultured for 48 hours in
DMEM medium, and lysed in 0.1% NP-40 buffer
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA
and complete protease inhibitors and phosphatase inhibi-
tors (Thermo Scientific)). Lysates were cleared by
centrifugation at 14,000 × g and subjected to co-immuno-
precipitations of protein complexes using anti-HA (clo-
ne12CA5) sepharose beads. Purified complexes and
control lysate (10 μg of total protein) samples were
separated on Nu-PAGE Bis-Tris 4-12% gels (Invitrogen),
and MYC and HA tagged proteins were detected using
standard immunoblotting techniques. Antibodies used
were mouse monoclonal anti-MYC (clone 9E10, Sigma)
and monoclonal anti-HA (clone HA.11, Covance).
Database searches
The Textpresso database [52] was used to search for
interactions were both bait and prey proteins had public
alphanumeric gene names. GO terms attributes were
retrieved from Wormbase. Note that in C. elegans most
attributes are currently inferred from electronic annota-
tion (IEA).
Additional material
Additional file 1: Definition of consensus classes. Additional file 1 is a
table describing the consensus classes used in this study. We defined for
this study three extended consensus classes encompassing the different
definitions available so far, so as to have the broadest definition of
classes [1,10].
Additional file 2: PDZ domains cloning and annotations. Additional
file 2 contains two tables (S1 and S2) listing for each PDZ domain
identified, respectively the primer sequences and the Gene Ontology
annotations. Supplemental Table S1: List of primers used to clone PDZ
domains. Proteins names and IDs are given according to Wormbase
WS150 [44]. For multiple PDZ domains in the same protein, a “.n”
extension was added to the ID of the PDZ containing protein. This
extension was numbered from the ATG (eg: F54E7.3.1 is the ID for the
first PDZ domain of F54E7.3). When only one PDZ was present, protein
ID was kept as such. Coordinates on PDZ domain containing proteins
correspond to the splice form specified in the third column (PDZ
domain containing protein ID). Each primer contains the B1 and B2
Gateway recombination cloning tail. Supplemental Table S2: Gene
Ontology annotation based on experimental data for PDZ domains
proteins. Gene ontology annotations were retrieved from Wormbase
WS190 [16]. Experimental Evidence Codes: EXP: Inferred from Experiment,
IDA: Inferred from Direct Assay, IPI: Inferred from Physical Interaction, IMP:
Inferred from Mutant Phenotype, IGI: Inferred from Genetic Interaction,
IEP: Inferred from Expression Pattern.
Additional file 3: PDZome network. Additional file 3 contains four
tables (S3 to S6) listing the PDZome network interacting pairs and giving
statistical analysis of the interactions. Supplemental Table S3: Two hybrid
screen results. Gene names and ID are given according to Wormbase
WS150[44]. Number of hits refers to the number of independent colonies
identified and phenotypically tested for each interacting partner. Number
of splice-forms identified or predicted in Wormbase WS150 and last 6
amino acids of each splice-form are given in cases were several splice-
forms are identified or predicted. When sequencing from the N-terminus
did not span the entire fragment, and thus the C-terminus was not
experimentally confirmed, if any of the predicted splice-form had a C-
terminal consensus motif, to be conservative, a consensus class was
attributed. Consensus class type: [ST]X[YFWCMVILA] = 1; [YFWCMVILA]X
[YFWCMVILA] = 2; [DE]X[YFWCMVILA] = 3 (X: any amino acid).
Supplemental Table S4: Promiscuity and specificity of PDZ interactome
network. Number of independent interacting proteins per PDZ domain,
and number of PDZ domains interacting with each protein are given for
AD-wrmcDNA and AD-ORFeome libraries two-hybrid screens.
Supplemental Table S5: Promiscuity and specificity of PDZ interactome
network: mean and median for number of interacting proteins per PDZ
or vice versa. Supplemental Table S6: Number of interacting proteins per
consensus class in network. Single hits: interacting proteins for which
only one clone was identified in two-hybrid screens. Multiple hits:
interacting proteins for which more than one clone was identified in
two-hybrid screens.
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Page 9 of 11Additional file 4: Functional annotation of interacting proteins.
Additional file 4 contains three tables (S7 to S9) listing the functional
annotations of the PDZ domain interacting proteins. Supplemental Table
S7: Concise description, GO terms and KOG (EuKaryotic Orthologous
Groups), for each interacting protein when available, retrieved from
Wormbase WS 190 [16]; note that most attributes are inferred from
electronic annotation. Experimental Evidence Codes: EXP: Inferred from
Experiment, IDA: Inferred from Direct Assay, IPI: Inferred from Physical
Interaction, IMP: Inferred from Mutant Phenotype, IGI: Inferred from
Genetic Interaction, IEP: Inferred from Expression Pattern. Computational
Analysis Evidence Codes: ISS: Inferred from Sequence or Structural
Similarity, ISO: Inferred from Sequence Orthology, ISA: Inferred from
Sequence Alignment, ISM: Inferred from Sequence Model, IGC: Inferred
from Genomic Context, RCA: inferred from Reviewed Computational
Analysis. Author Statement Evidence Codes: TAS: Traceable Author
Statement, NAS: Non-traceable Author Statement. Curator Statement
Evidence Codes: IC: Inferred by Curator, ND: No biological Data available.
Automatically-assigned Evidence Codes: IEA: Inferred from Electronic
Annotation. Supplemental Table S8: Classification of interacting proteins
according to Cellular Components terms: integral to membrane, nucleus
and other&unknown. Supplemental Table S9: Classification of interacting
proteins according to Biological Processes: manual curation of
annotations retrieved from Wormbase WS190 were used to define the 11
groups of processes shown in Figure 2.
Additional file 5: Verification of two-hybrid interacting pairs by co-
immunoprecipitation. Additional file 5 contains four tables (S10 to S13)
listing interacting proteins pairs tested and results. Supplemental Table
S10 lists tested pairs involving PDZ domains and their respective two-
hybrid identified interacting proteins possessing a free C-terminus.
Supplemental Table S11 lists tested pairs involving PDZ domains and
their respective two-hybrid identified interacting proteins using a B2
tailed construct. Supplemental Table S12 lists the 59 protein fragments
that did not possess a C-terminal binding motif tested by co-
immunoprecipitation in a C-terminally truncated form against their
respective two hybrid interacting PDZs. Sequences where there was
creation of a new C-terminal consensus sites after truncation are shown.
Supplemental Table S13 lists the primers pairs used to amplify and clone
truncated interacting protein fragments used in the co-
immunoprecipitation experiment.
Additional file 6: Co-IP verification of yeast two hybrid interacting
pairs identified in AD-wrmcDNA and AD-ORFeome screens using a
B2 tailed construct. Additional file 6 is a figure showing the Co-IP
verification of yeast two hybrid interacting pairs identified in AD-
wrmcDNA and AD-ORFeome screens using a B2 tailed construct. (A)
Schematic representation of PDZ domains carrying N-terminal 3XHA
epitope tag and of their interacting protein, ending with the B2 tail,
carrying N-terminal MYC epitope. (B) Each pair of constructs to be tested
was co-expressed in 293T cells and co-IP was performed using cellular
lysates subjected to precipitation with anti-HA sepharose. Presence of
interacting protein upon precipitation was revealed by western blotting
using anti-MYC serum. For each IP performed three panels are presented.
Upper panel: IP reaction probed upon resolution on SDS-PAGE and
blotting with anti-HA antibody detecting HA-PDZ domain; Middle panel:
the same IP reaction probed with anti-MYC serum detecting ORF (MYC:
ORF); lower panel: detection of expression of each ORF by probing total
crude cellular extracts (input) with anti-MYC serum. Table summarizes the
interaction pairs tested and color code is used to indicate the outcome
(purple: interaction tested positive, grey: no interaction and yellow:
inconclusive as one or both partners are not expressed). (C) Each ORF
used in above co-IP experiment was also subjected to co-transfection
and co-immunoprecipitation with empty pDEST-CMV-3xHA vector to
serve as a negative control for the binding assay. Detection and analysis
were performed as above.
Additional file 7: Negative controls of immunoprecipitations shown
in Figure 4. Additional file 7 is a figure showing the test for unspecific
binding of non-consensus C-terminally truncated proteins (MYC:
MIRdCter) to irrelevant HA epitoped peptide in co-immunoprecipitation
reaction corresponding to negative control of the experiment described
in Figure 4. Each MYC:MIRdCter construct was co-expressed in 293T cells
together with empty pDEST-CMV-3xHA vector and co-IPed using anti-HA
sepharose beads. Binding of given protein upon precipitation was
revealed by western blotting using anti-MYC serum. For each IP
performed three panels are presented. Upper panel: IP reaction probed
after resolution on SDS-PAGE and blotting with anti-HA antibody. Middle
panel: the same IP reaction probed with anti-MYC serum detecting the
truncated protein fragments (MYC:MIRdCter). Lower panel: detection of
expression of each truncated protein fragment by probing total crude
cellular extracts (input) with anti-MYC serum.
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